-The Times of India NEW DELHI: India's march towards being an economically stable nation is threatened not just by global financial issues. Poor health indicators pose an equally big threat. The Harvard School of Public Health has, in a study on economic losses due to non-communicable diseases (NCDs), estimated that the economic burden of these ailments for India will be close to $6.2 trillion for the period 2012-30, a figure that is...
More »SEARCH RESULT
Total Matching Records found : 247
Non communicable diseases causing more premature deaths in India now -Jyotsna Singh
-Down to Earth World Bank report says heart diseases have replaced TB and sepsis as two of the five leading causes of deaths between 1990 and 2010 Reasons for premature deaths in India have seen a significant shift over the past two decades. In 1990, the top five reasons were communicable diseases. In 2010, two of the top five reasons for premature deaths are non-communicable diseases (NCDs). Diet-related risks are the leading...
More »This perverse rage against the poor-Harish Khare
-The Hindu With the economic boom petering out, those who benefitted from it are angry with the government for the Food Security Bill because it is paying attention to the needs of the underprivileged for a change This week's received wisdom insists that the Indian economy has irretrievably collapsed because on Monday, the Lok Sabha passed the National Food Security Bill (NFSB). The Hindu Business Line headline (Aug.28, page 1) said it...
More »‘Will the big people send my husband back home?’-Pheroze L Vincent
-The Hindu Maganlal Barela's wife says he loved his daughters, whom he is accused of killing, the most KANERIA VILLAGE (MP): The fragrance of lantana is overpowering as you approach the home of Maganlal Barela, who is on death row for hacking his five daughters to death on June 11, 2010. Supreme Court stayed his execution late on Wednesday night, just hours before the appointed time on Thursday. The mud huts of Maganlal,...
More »Another bitter pill for patients-Sakthivel Selvaraj
-The Hindu The current market prices are essentially over and above the actual cost of production - a difference that could run from 100 per cent to 5,600 per cent, depending upon various therapeutic categories In a liberalised market economy, do we need price controls on drugs? Policymakers and the pharmaceutical industry do not think so. They believe that price controls are an inefficient tool that distorts resource allocation, squeezes revenue, reduces...
More »
